LR Health & Beauty SE, Europe's leading social commerce company for high-quality nutritional supplements and beauty products, has published its final annual report for 2025, confirming the preliminary sales and earnings figures. The company reported sales of EUR 277.1 million for the full year 2025, down from EUR 289.2 million in 2024. Reported EBITDA declined to EUR 16.5 million from EUR 27.3 million, impacted by one-off effects from the reorganization of the financing structure. Normalized EBITDA, which excludes these effects, stood at EUR 22.5 million, compared to EUR 32.6 million in the prior year.
The announcement underscores the company's strategic focus on long-term growth. Jörg Korfer, CEO of LR Health & Beauty SE, emphasized that 2026 is a transitional year, with groundwork laid both financially and strategically to achieve sustainable business growth. He noted that the newly established financing structure provides momentum to consistently pursue initiatives in production, logistics, and sales. The company is committed to working closely with its partners and expanding these relationships internationally.
A key strategic pillar is expanding in-house production. LR is investing over 2 million euros in a new, high-performance production line, which will centralize the manufacture of its 5in1 product category entirely at its site in Ahlen. This includes the established products LR 5in1 Beauty Elixir and LR 5in1 Men's Shot. The new facility is designed to have an annual capacity of up to 40 million units and will also facilitate further product innovations in modern nutritional supplement concepts.
This investment is significant as it enhances operational efficiency and allows for greater control over production quality and costs. By centralizing production, LR aims to optimize its supply chain and better respond to market demands. The increased capacity also positions the company to scale its popular product lines and introduce new offerings, which could drive future revenue growth.
The full 2025 Annual Report is available on the company's website at https://ir.lrworld.com. LR Health & Beauty SE, headquartered in Ahlen, Germany, operates in 32 countries, distributing nutritional supplements and cosmetics under the motto "More quality for your life." The company leverages digital tools like "LR neo" to support its social commerce model, emphasizing personal consultation and flexibility for its partners.
For over two decades, LR has specialized in aloe vera processing, using only the valuable inside of the leaf in its products. The company has built one of Europe's most modern aloe vera production facilities for drinking gels. Additionally, through the LR Global Kids Fund e.V., founded in 2009, LR supports disadvantaged children and families worldwide, reflecting its commitment to social responsibility.
The confirmation of the 2025 results and the ongoing strategic initiatives signal that LR is positioning itself for recovery and growth. The investment in production capacity is a forward-looking move that could enhance competitiveness and profitability in the coming years.
